![1]()
News
Understanding properties of fentanyl, other opioids key to treatment
December 14, 2018
BONITA SPRINGS, FLA. – Fentanyl has opioid receptor affinity similar to that of morphine, research shows, and it’s not known why it is up to 100 times more potent than morphine.
![1]()
News
Drug test results ‘should not dictate treatment’
December 13, 2018
BONITA SPRINGS, FLA. – Many clinicians say they’re unsure about interpreting urine drug screens, but a 30-minute training session can make a big difference, said Dr. Rebecca Ann Payne.
![1]()
Video
Social media can help doctors stay up to date
December 11, 2018
SAN DIEGO – Dr. Amber Yates said being active on Twitter has helped her streamline the journals she reads.
![1]()
News
Phone app diagnoses STEMI nearly as well as ECG
December 7, 2018
CHICAGO – With some tweaking, the AliveCor app could improve outcomes by speeding up diagnosis and treatment.
![1]()
News
Acute stroke thrombolysis worked safely despite GI bleed or malignancy
December 7, 2018
CHICAGO – Current guidelines contraindicate acute stroke thrombolysis in patients with GI bleed or malignancy, but a new analysis suggests it’s safe.
![1]()
News
EARLY: Angiography within 2 hours of acute non-ST event cut recurrent ischemic events
December 4, 2018
Coronary angiography immediately after an acute non–ST-segment elevation coronary event limited recurrent events, compared with later intervention.
![1]()
Video
ARISTOPHANES: Apixaban edges other DOACS for octogenarians
December 2, 2018
CHICAGO – Insurance claims data from more than 50,000 U.S. octogenarians on a DOAC showed apixaban worked best and caused the fewest major bleeds.
![1]()
News
Feds call for EHR interoperability. Again.
November 29, 2018
“Patients need to be able to access their own records. Period,” HHS Deputy Secretary Eric Hargan said.
![1]()
News
Nasal glucagon ‘viable alternative’ to intramuscular administration
November 20, 2018
BERLIN – Severe hypoglycemia was reversed successfully in all patients with type 1 diabetes mellitus given nasal glucagon.
![1]()
News
New pediatric therapies show promise for influenza, multidrug-resistant pathogens
November 14, 2018
ORLANDO – Baloxavir, a recently approved fast-acting single-dose medication for influenza, is currently under study in children.
